(HealthDay)—Defitelio (defibrotide sodium) has been approved by the U.S. Food and Drug Administration to treat a rare, but usually fatal liver disease that affects some people who have had a stem cell transplant.
Mar 30, 2016
Research from Keck School of Medicine at the University of Southern California (USC) suggests that hormone therapy, when taken within six years of menopause, may slow the progression of subclinical atherosclerosis, the buildup ...
Mar 30, 2016
The U.S. presidential campaign season has reignited debates on how best to deliver cost-effective, high quality care. A new perspective paper in the New England Journal of Medicine advocates for a comprehensive approach to ...
Mar 30, 2016
In a multicenter, randomized clinical trial, ex-prisoners who received six monthly injections of naltrexone—a long-acting medication that blocks opioid receptors in the brain—were significantly less likely to resume opioid ...
Mar 30, 2016
Two recently discovered compounds have shown promise in preclinical studies for treating Ewing sarcoma, a rare cancer that predominantly affects children and adolescents.
Mar 30, 2016
Learning difficulties and behavioral problems during childhood can lead to suboptimal social and educational outcomes among young adults with childhood epilepsy even when their seizures are well under control and their disease ...
Mar 30, 2016
Eating one serving a day of beans, peas, chickpeas or lentils could contribute to modest weight loss, a new study suggests.
Mar 30, 2016
